Jiřina Procházková

Post‐translational modifications regulate signalling by Ror1

Š. Pospíšilová, S. Pavlova, V. Bryja, 2011, Acta physiologica.

Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

P. Jindra, A. Folta, T. Papajík, 2024, Leukemia.

Transcriptional and phenotypical alterations associated with a gradual benzo[a]pyrene-induced transition of human bronchial epithelial cells into mesenchymal-like cells

J. Vondráček, M. Machala, H. Líbalová, 2024, Environmental Toxicology and Pharmacology.

Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives.

J. Vondráček, Z. Kahounová, Jiřina Procházková, 2024, Transcription.